![Promising Results for Structure Therapeutics’ Oral Diabetes and Obesity Pill in Mid-Stage Trial](https://www.glphub.com/wp-content/uploads/2023/12/photo-1581159186721-b68b78da4ec9.jpeg)
Promising Results for Structure Therapeutics’ Oral Diabetes and Obesity Pill in Mid-Stage Trial
Unlike the existing GLP-1 agonists such as Wegovy, Ozempic and Zepbound, which require injections, GSBR-1290 offers the convenience of oral administration.